Anika Therapeutics | ANIK - Ebitda

Anika Therapeutics reported $-2947000 in EBITDA for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Ebitda Change
Abbott ABT:US USD 2.13B 454M
Acorda Therapeutics ACOR:US USD 7.96M 5.15M
Agenus AGEN:US USD -55733000 15.79M
Agios Pharmaceuticals AGIO:US USD -97358000 8.25M
Anika Therapeutics ANIK:US USD -2947000 644K
Arrowhead Research ARWR:US USD -39434000 41.74M
Clovis Oncology CLVS:US USD -42347000 15.13M
Enanta Pharmaceuticals ENTA:US USD -29502000 3.11M
Halozyme Therapeutics HALO:US USD 83.06M 29.83M
Heron Therapeutics HRTX:US USD -41176000 7.65M
Immunogen IMGN:US USD -59131000 17.87M
Insmed INSM:US USD -149714000 29.85M
Integra Lifesciences IART:US USD 109.7M 4.38M
Intrexon XON:US USD -20076000 14.18M
Johnson & Johnson JNJ:US USD 7.34B 1.2B
Ligand Pharmaceuticals LGND:US USD -11560000 25.67M
Macrogenics MGNX:US USD 15.21M 37.32M
Merit Medical Systems MMSI:US USD 51.46M 12.39M
Sangamo Biosciences SGMO:US USD -52049000 204K
Smith & Nephew PLC SN/:LN 644M 21M
Stryker SYK:US USD 1.48B 389M
Surmodics SRDX:US USD -5107000 734K
Veracyte VCYT:US USD 1.14M 4.49M
Xencor XNCR:US USD -40434000 4.32M
Zimmer Biomet Holdings Inc ZBH:US USD 610.5M 85.6M